Comparing Medium-Term Clinical Outcomes following XEN® 45 and XEN® 63 Device Implantation

Figure 2

Change in number of IOP-lowering medications required by the patient over 12, 24, and 36 months follow-up visits XEN® 45 and XEN® 63.